Diadema Partners »

Shattuck Labs shares owned by Diadema Partners

Quarter-by-quarter ownership of Shattuck Labs (STTK) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Shattuck Labs

Tip: Access up to 7 years of quarterly data

All positions including Shattuck Labs held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Shattuck Labs by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 294k 6.43

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Shattuck Labs

OrbiMed Advisors
Redmile Group
Prosight Management
Adage Capital Partners GP
Vanguard Capital Management
Gail Mannix
T. Rowe Price Associates
Clark Estates
Standard Life Aberdeen
Point72 Asset Management
Ameriprise Financial
683 Capital Management
Millennium Management
Susquehanna International
Geode Capital Management

View all funds holding Shattuck Labs